0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Presidential Address | 
Ashby C. Moncure, MD
Arch Surg. 2001;136(4):376-382. doi:10.1001/archsurg.136.4.376.
Sign in to download this free article PDF

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Editorial  | 
Hematopoietic Stem Cell Transplantation for MS:  Extraordinary Evidence Still Needed
Stephen L. Hauser, MD
JAMA
Preliminary Communication  | 
Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Richard K. Burt, MD; Roumen Balabanov, MD; Xiaoqiang Han, MD; et al.
JAMA
Original Investigation  | 
Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System
Nikolai Madrid Scheller, MB; Henrik Svanström, MSc; Björn Pasternak, MD, PhD; et al.
JAMA Neurology
Case Report/Case Series  | 
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis
Robert Fleischmann, MD; Harald Prüss, MD; Berit Rosche, MD; et al.